Patient, public, and clinician research co-productions make this a directive Article collection. For those interested in understanding perspectives and learning how to promote engagement in rheumatic and musculoskeletal contexts.
We are pleased to announce that BMC Rheumatology has been accepted for indexing in Clarivate's Emerging Sources Citation Index™ (ESCI). Journal content is available to view in Web of Science's indexing database. A list of all sources where BMC Rheumatology is indexed can be found here, which includes PubMed Central and Scopus.
Editor's article highlights
Aims and scope
BMC Rheumatology is an open access, peer-reviewed journal that considers pre-clinical, translational and clinical articles on all aspects of the prevention, treatment and management of rheumatological diseases, related systemic and inflammatory conditions and associated comorbidities, as well as epidemiology, education, pathophysiology, genetics, and drug development.
For authors based in low- and middle-income countries who might face challenges in publishing their work. Follow us for guidance on submitting your research to us.
We are recruiting new Editorial Board Members
We are recruiting new Editorial Board Members to join our international community of experts, helping to provide expertise on a wide range of subjects within the area of rheumatology.Read More
BMC Series blog
01 December 2023
27 November 2023
Annual Journal Metrics
2022 Citation Impact
2.2 - 2-year Impact Factor
2.9 - 5-year Impact Factor
0.891 - SNIP (Source Normalized Impact per Paper)
0.703 - SJR (SCImago Journal Rank)
18 days submission to first editorial decision for all manuscripts (Median)
138 days submission to accept (Median)
1,275 Altmetric mentions
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication